S
Skope
Guest
- Thread Author
- #1
Preclinical investigation into multi-receptor incretin mimetics has expanded substantially, with particular focus on the triple-hormone receptor agonist Retatrutide (investigational code LY3437943; CAS 2381089-83-2). Characterized in its primary discovery literature as exhibiting potent activity at the human glucose-dependent insulinotropic polypeptide receptor (GIPR) alongside balanced activity…
Source
Source